(Q38192816)

30 August 2017

1 reference

17 November 2019

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation (English)

1 reference

local neoplasm recurrence

30 August 2017

1 reference

17 November 2019

1 reference

17 November 2019

1 reference

17 November 2019

1 reference

3 April 2019

1 reference

11 October 2019

1 reference

17 November 2019

1 reference

Zhen Li

6

0 references

author name string

Julia Lipianskaya

1

1 reference

30 August 2017

Alexa Cohen

2

1 reference

30 August 2017

Clark J Chen

3

1 reference

30 August 2017

Elaine Hsia

4

1 reference

30 August 2017

Jill Squires

5

1 reference

30 August 2017

Yaqun Zhang

7

1 reference

30 August 2017

Wei Li

8

1 reference

30 August 2017

Xufeng Chen

9

1 reference

30 August 2017

Hua Xu

10

1 reference

30 August 2017

Jiaoti Huang

11

1 reference

30 August 2017

language of work or name

1 reference

1 July 2014

1 reference

Asian Journal of Andrology

30 August 2017

4 references

30 August 2017

9 October 2019

11 October 2019

17 November 2019

16

1 reference

30 August 2017

4

1 reference

30 August 2017

541-544

1 reference

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

30 August 2017

6 references

19 March 2019

24 March 2019

3 April 2019

9 October 2019

11 October 2019

on focus list of Wikimedia project

17 November 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Platinum-based chemotherapy for variant castrate-resistant prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Preneoplasia in the prostate gland with emphasis on high grade prostatic intraepithelial neoplasia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Androgen receptor antagonists in castration-resistant prostate cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Agents that target androgen synthesis in castration-resistant prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

A historical perspective on the role of stroma in the pathogenesis of benign prostatic hyperplasia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Neuroendocrine differentiation in prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Unusual and underappreciated: small cell carcinoma of the prostate.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Immunohistochemical characterization of neuroendocrine cells in prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Small cell carcinoma of the prostate: an immunohistochemical study.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Role of stroma in carcinogenesis of the prostate.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Small cell carcinoma of the prostate: an underrecognized entity

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104077

Two cases of small cell carcinoma of the prostate

3 December 2018

1 reference

12 December 2020

Small Cell Anaplastic Carcinoma of the Prostate: A Clinical, Pathological and Immunohistological Study of 27 Patients

1 reference

12 December 2020

Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors

1 reference

12 December 2020

Small cell carcinoma of the prostate

1 reference

12 December 2020

Large Cell Neuroendocrine Carcinoma of Prostate

1 reference

12 December 2020

Small cell anaplastic carcinoma of the prostate: report of a case with positive urine cytology

1 reference

12 December 2020

CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers

1 reference

12 December 2020

Identifiers

DOI

10.4103/1008-682X.123669

1 reference

30 August 2017

1 reference

30 August 2017

PubMed publication ID

24589459

1 reference